Increased protein-coding mutations in the mitochondrial genome of African American women with preeclampsia

Reproductive Sciences

Volumn 19, Issue 12, 2012, Pages 1343-1351

  Ding, David ^a   Scott, Nicole M ^a   Thompson, Emma E ^a   Chaiworapongsa, Tinnakorn ^b,d   Torres, Raul ^a   Billstrand, Christine ^a   Murray, Kathleen ^a   Dexheimer, Phillip J ^c   Ismail, Mahmoud ^a   Kay, Helen ^a   Levy, Shawn ^c   Romero, Roberto ^d   Lindheimer, Marshall D ^a   Nicolae, Dan L ^a   Ober, Carole ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

African American women; mtDNA; oxidative phosphorylation; preeclampsia

Indexed keywords

GENOMIC DNA; MITOCHONDRIAL DNA; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOSOME RNA; TRANSFER RNA;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENOME; HUMAN; HUMAN TISSUE; MITOCHONDRION; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANT WOMAN; PRIORITY JOURNAL; TROPHOBLAST;

ADULT; AFRICAN AMERICANS; CHICAGO; DNA, MITOCHONDRIAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, MITOCHONDRIAL; HAPLOTYPES; HUMANS; MUTATION; NADH DEHYDROGENASE; PRE-ECLAMPSIA; PREGNANCY; SEQUENCE ANALYSIS, DNA; TROPHOBLASTS; UMBILICAL CORD; YOUNG ADULT;

EID: 84868585829     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719112450337     Document Type: Article

References (54)

1. Ness R, Roberts J Chesley's Hypertensive Disorders in Pregnancy. 3 rd ed. San Diego, CA: Academic Press; 2009:37-50. Lindheimer M Roberts J Cunningham F, ed. San Diego, CA: Academic Press ; 2009: 37-50.
2. Villar J, Say L, Gulmezohlu A, et al Preeclampsia. Critchley H Maclean A Poston L Walker J, ed. RCOG Press ; 2003: 189-207.
3. Samadi A, Mayberry R, Zaidi A, et al. Maternal hypertension and associated pregnancy complications among African-American and other women in the United States. Obstet Gynecol. 1996 ; 87 (4). 557-563
4. Caughey AB, Stotland NE, Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol. 2005 ; 106 (1). 156-161
5. Tanaka M, Jaamaa G, Kaiser M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health. 2006 ; 97 (1). 163-170
6. Roberts JM, Redman CW. Pre-eclampsia: more than pregnancy-induced hypertension. Lancet. 1993 ; 341 (8858). 1447-1451
7. Redman CW. Current topic: pre-eclampsia and the placenta. Placenta. 1991 ; 12 (4). 301-308
8. Wang Z, Zhang G, Lin M. Mitochondrial tRNA(leu)(UUR) gene mutation and the decreased activity of cytochrome c oxidase in preeclampsia. J Tongji Med Univ. 1999 ; 19 (3). 209-211
9. Wang Y. Placental mitochondria as a source of oxidative stress in pre-eclampsia. Placenta. 1998 ; 19 (8). 581-586
10. Wang Y, Walsh SW, Kay HH. Placental lipid peroxides and thromboxane are increased and prostacyclin is decreased in women with preeclampsia. Am J Obstet Gynecol. 1992 ; 167 (4 pt 1). 946-949
11. Gupta S, Agarwal A, Sharma RK. The role of placental oxidative stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005 ; 60 (12). 807-816
12. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell. 2005 ; 120 (4). 483-495
13. Torbergsen T, Oian P, Mathiesen E, Borud O. Pre-eclampsia-a mitochondrial disease?. Acta Obstet Gynecol Scand. 1989 ; 68 (2). 145-148
14. Berkowitz K, Monteagudo A, Marks F, Jackson U, Baxi L. Mitochondrial myopathy and preeclampsia associated with pregnancy. Am J Obstet Gynecol. 1990 ; 162 (1). 146-147
15. Folgerø T, Storbakk N, Torbergsen T, Oian P. Mutations in mitochondrial transfer ribonucleic acid genes in preeclampsia. Am J Obstet Gynecol. 1996 ; 174 (5). 1626-1630
16. Jauniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involvement of oxidative stress and implications in human evolution. Hum Reprod Update. 2006 ; 12 (6). 747-755
17. Shanklin DR, Sibai BM. Ultrastructural aspects of preeclampsia. II. Mitochondrial changes. Am J Obstet Gynecol. 1990 ; 163 (3). 943-953
18. Widschwendter M, Schrocksnadel H, Mortl M. Pre-eclampsia: a disorder of placental mitochondria?. Mol Med Today. 1998 ; 4 (7). 286-291
19. DiMauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med. 2003 ; 348 (26). 2656-2668
20. Vuorinen K, Remes A, Sormunen R, Tapanainen J, Hassinen IE. Placental mitochondrial DNA and respiratory chain enzymes in the etiology of preeclampsia. Obstet Gynecol. 1998 ; 91 (6). 950-955
21. Metzker ML. Sequencing technologies-the next generation. Nat Rev Genet. 2010 ; 11 (1). 31-46
22. Lindheimer MD, Taler SJ, Cunningham FG. Hypertension in pregnancy. J Am Soc Hypertens. 2010 ; 4 (2). 68-78
23. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000 ; 183 (1). S1 - S22
24. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009 ; 10 (3). R25
25. Cann RL, Stoneking M, Wilson AC. Mitochondrial DNA and human evolution. Nature. 1987 ; 325 (6099). 31-36
26. van Oven M, Kayser M. Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 2009 ; 30 (2). E386-394
27. Behar DM, Villems R, Soodyall H, et al. The Dawn of Human Matrilineal Diversity. Am J Hum Genet. 2008 ; 82 (5). 1130-1140
28. Salas A, Richards M, Lareu M-V, et al. The African diaspora: mitochondrial DNA and the Atlantic slave trade. Am J Hum Genet. 2004 ; 74 (3). 454-465
29. Gonder MK, Mortensen HM, Reed FA, de Sousa A, Tishkoff SA. Whole-mtDNA genome sequence analysis of ancient African lineages. Mol Biol Evol. 2006 ; 24 (3). 757-768
30. EltsovNVolodkoNStarikovskayaESukernikR. New tool (mtPHYL) proposed for phylogenetic analysis of human complete mitochondrial genomes. http://eltsov.org/mtphyl.aspx. Accessed February 2, 2011.
31. Ingman M, Gyllensten U. Analysis of the complete human mtDNA genome: methodology and inferences for human evolution. J Hered. 2001 ; 92 (6). 454-461
32. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996 ; 87 (2). 163-168
33. Pichler I, Fuchsberger C, Platzer C, et al. Drawing the history of the Hutterite population on a genetic landscape: inference from Y-chromosome and mtDNA genotypes. Eur J Hum Genet. 2009 ; 18 (4). 463-470
34. Chaiworapongsa T, Romero R, Espinoza J, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 2004 ; 190 (6). 1541-1547
35. Kusanovic JP, Romero R, Jodicke C, et al. Amniotic fluid soluble human leukocyte antigen-G in term and preterm parturition, and intra-amniotic infection/inflammation. J Matern Fetal Neonatal Med. 2009 ; 22 (12). 1151-1166
36. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006 ; 355 (10). 992-1005
37. Romero R, Chaiworapongsa T, Erez O, et al. An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study. J Matern Fetal Neonatal Med. 2010 ; 23 (12). 1384-1399
38. Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008 ; 21 (1). 9-23
39. LiuX-LZhouXZhouJLeber's hereditary optic neuropathy is associated with the T12338C mutation in mitochondrial ND5 gene in six Han Chinese families. Ophthalmology. 2010. http://www.ncbi.nlm.nih.gov/pubmed/21131053
40. Zou Y, Jia X, Zhang A-M, et al. The MT-ND1 and MT-ND5 genes are mutational hotspots for Chinese families with clinical features of LHON but lacking the three primary mutations. Biochem Biophys Res Commun. 2010 ; 399 (2). 179-185
41. Liolitsa D, Rahman S, Benton S, Carr LJ, Hanna MG. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations?. Ann Neurol. 2003 ; 53 (1). 128-132
42. Shanske S, Coku J, Lu J, et al. The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol. 2008 ; 65 (3). 368-372
43. Bai Y, Shakeley RM, Attardi G. Tight control of respiration by NADH dehydrogenase ND5 subunit gene expression in mouse mitochondria. Mol Cell Biol. 2000 ; 20 (3). 805-815
44. Brown WM, George M, Wilson AC. Rapid evolution of animal mitochondrial DNA. Proc Natl Acad Sci U S A. 1979 ; 76 (4). 1967-1971
45. Fay JC, Wu CI. A human population bottleneck can account for the discordance between patterns of mitochondrial versus nuclear DNA variation. Mol Biol Evol. 1999 ; 16 (7). 1003-1005
46. Sigurõardóttir S, Helgason A, Gulcher JR, Stefansson K, Donnelly P. The mutation rate in the human mtDNA control region. Am J Hum Genet. 2000 ; 66 (5). 1599-1609
47. Chen YS, Torroni A, Excoffier L, Santachiara-Benerecetti AS, Wallace DC. Analysis of mtDNA variation in African populations reveals the most ancient of all human continent-specific haplogroups. Am J Hum Genet. 1995 ; 57 (1). 133-149
48. Ingman M, Kaessmann H, Pääbo S, Gyllensten U. Mitochondrial genome variation and the origin of modern humans. Nature. 2000 ; 408 (6813). 708-713
49. Parra EJ, Marcini A, Akey J, et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet. 1998 ; 63 (6). 1839-1851
50. Zakharia F, Basu A, Absher D, et al. Characterizing the admixed African ancestry of African Americans. Genome Biol. 2009 ; 10 (12). R141
51. Chevrollier A, Guillet V, Loiseau D, et al. Hereditary optic neuropathies share a common mitochondrial coupling defect. Ann Neurol. 2008 ; 63 (6). 794-798
52. Santorelli FM, Shanske S, Macaya A, DeVivo DC, DiMauro S. The mutation at nt 8993 of mitochondrial DNA is a common cause of Leigh's syndrome. Ann Neurol. 1993 ; 34 (6). 827-834
53. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies-disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011 ; 30 (2). 81-114
54. Bu XD, Rotter JI. X chromosome-linked and mitochondrial gene control of Leber hereditary optic neuropathy: evidence from segregation analysis for dependence on X chromosome inactivation. Proc Natl Acad Sci U S A. 1991 ; 88 (18). 8198-8202